Hello SEA-AD team,
I am preparing a donor-level secondary analysis using the publicly released June 2026 SEA-AD quantitative neuropathology summary and processed MTG endothelial pseudobulk data. I would appreciate clarification of one measurement before defining the analysis.
I reviewed the public standardization code and confirmed that the released MTG Grey matter colocalization percentage is an area-weighted average of the layer-level percentages, while object counts are summed across layers. This reproduces the Grey matter percentages for all 84 donors, so I am not treating the difference between a Grey matter percentage and a ratio of summed counts as a data error.
The remaining question concerns the original layer-level percentage. For example, in the archived MTG table, donor H21.33.045, Layer2 has:
- 1,569 IBA1–6E10 colocalized objects
- 1,216 6E10-positive objects
- a reported colocalization percentage of approximately 20.1438%
Could someone clarify:
- What exact HALO export fields and formula define the layer-level percentage?
- Are the colocalized objects object pairs, overlap segments, IBA1 objects, or 6E10 objects? Can one object contribute multiple matches?
- Are the IBA1 objects in the Object Colocalization module segmented in the same way as the IBA1-positive cells reported by the separate Microglia module?
- How should a layer with zero 6E10-positive objects be interpreted when a percentage is reported?
- Is the original I6-MTG-Summary data-08-10-22.csv export, a field dictionary, or a worked example available?
- For the June 2026 endothelial expression release, should donors carrying the older “Severely Affected Donor” flag be excluded, or is that issue handled by the newer nucleus-level QC pipeline?
I am not assuming that the released values are erroneous. I would like to avoid describing this measure as a simple fraction of plaques contacted or engulfed by IBA1-positive cells unless that interpretation is supported by the original image-analysis definition.
Thank you for any guidance.
— Alexy